|
WO2020102108A1
|
|
Compositions and methods of modulating inflammation
|
|
US2020237892A1
|
|
Flavivirus peptide sequences, epitopes, and methods and uses thereof
|
|
EP3781173A1
|
|
Modulating immune response via targeting of olfactory receptor activity
|
|
US2021015866A1
|
|
Tissue resident memory cell profiles, and uses thereof
|
|
CN111601882A
|
|
Use and production of engineered immune cells
|
|
US2020224200A1
|
|
Modulation of immune response through stimulator of interferon genes
|
|
WO2019032921A1
|
|
An anti-apoptotic function of pkm2 and intracellularly expressed scfv antibodies
|
|
WO2019028295A1
|
|
Compositions and methods for the isolation and/or generation of specific cd4+ and cd8+ t-cell subsets
|
|
WO2018236909A1
|
|
Engineered t-cell receptors and methods of their use in modulating inflammatory responses and treating atherosclerosis
|
|
WO2018204690A1
|
|
Diagnosis and treatment of infection involving killer t follicular helper cells, methods of preparation, and uses thereof
|
|
US2021088505A1
|
|
Unipotent Neutrophil Progenitor Cells, Methods of Preparation, and Uses Thereof
|
|
WO2018148499A1
|
|
Flavivirus peptide sequences, epitopes, and methods and uses thereof
|
|
WO2018106972A1
|
|
Compositions for cancer treatment and methods and uses for cancer treatment and prognosis
|
|
WO2018089835A1
|
|
A pro-inflammatory role for adenosine uptake and metabolism
|
|
WO2018089661A1
|
|
Use of c-terminally extended peptides to disrupt inhibitor nk cell receptor interactions with mhc i
|
|
WO2017177204A1
|
|
Leveraging immune memory from common childhood vaccines to fight disease
|
|
WO2017196432A1
|
|
Compositions and methods for diagnosing and treating neurodegenerative disease
|
|
WO2017176385A1
|
|
Compositions and methods for diagnosing and treating brain injury
|
|
US2018369330A1
|
|
Methods and compositions using integrin-based therapeutics
|
|
WO2017112830A1
|
|
Leveraging immune memory from common childhood vaccines to fight disease
|
